Literature DB >> 26918096

Giant Dural Supratentorial Chondroma Generating the Question of How Large Can a Tumor Become Without Revealing Itself.

Alexandros Doukas1, Annamarie Tallo2, Richard Parvin3, Volkmar Hans4, Pooya Daemi2, Azad Cheko2, Martin Scholz2, Athanasios K Petridis2.   

Abstract

Chondromas usually affect the small bones of hand and feet and account for only 0.5% of all intracranial tumors. We present a case of a giant, supratentorial meningeal chondroma in a 19-year old male patient and discuss the preoperative diagnostic findings as well as the appropriate treatment options. A 19-old male presented with headache, new onset of focal seizures and paresis of left upper extremity. Magnetic resonance imaging revealed a large right parietal tumor in the precentral region with local mass effect. The patient underwent right parietal craniotomy and gross total resection of the tumor. The histopathological report revealed a chondroma. Intradural supratentorial chondromas are extremely rare. As with other slow growing intracranial masses, they often reach a relatively large size before generating symptoms. Maximal surgical resection is the treatment of choice and if this is achieved no adjuvant therapy is necessary.

Entities:  

Keywords:  Chondroma; eloquent; supratentorial

Year:  2015        PMID: 26918096      PMCID: PMC4745590          DOI: 10.4081/cp.2015.777

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


Introduction

Intracranial chondromas account for only 0,5% of all primary intracranial tumors. They usually arise in the skull base and especially in the sphenopetrosal, sphenoclival or petroclival junctions.[1-3] They tend to engulf cranial nerves or major arteries and become symptomatic with cranial nerve palsies or headaches. They grow slowly and are considered benign as opposed to their malignant relatives the chondrosarcomas. The histological differentiation between the two can be challenging and has enormous significance regarding their therapy.

Case Report

A 19-year old male was admitted with complains of headache, hyperventilation and new onset of focal seizures. There was no significant family history, especially no history of tumor. The patient received no medication and had no history of radiation therapy. On clinical examination higher mental functions were intact. The patient was in postictal recovery and presented a paresis of the left upper extremity. Magnetic resonance imaging (MRI) scan revealed a giant mass in the right precentral gyrus measuring 5×6×6 cm (Figure 1A and B). The corticospinal fibers as well as the motoric areas in the precentral gyrus were displaced anteriorly and posteriorly around the tumor (Figure 1C-E) On MRI imaging the tumor mass showed intermediate signal intensity on T1 weighted and high signal intensity on T2 weighted images as well as heterogeneous enhancement with typical honeycomb appearance. The patient underwent surgical treatment via a right parietal craniotomy. The dura overlying the tumor mass was irregularly distended. The partially involved dura and the tumor were dissected from the cortical surface without difficulty. The intracranial mass was completely removed in a piecemeal fashion. Since the bone did not seem to be involved in the tumor process we drilled the inner table of the calvaria but did not remove the bone completely. The removed tumor mass was macroscopically multinodular, ivory colored with a very cartilaginous consistency (Figure 2). The patient had postoperatively no motor or sensory deficits. The histological diagnosis revealed a chondroma (Figure 3). The postoperative computed tomography (CT) brain scan confirmed the total excision of the tumor (Figure 4A). The patient was placed on appropriate antiepileptic drugs and made a good recovery. He was discharged on the 12th postoperative day. Following gross total resection and after establishment of the histological diagnosis no adjuvant therapy was needed. The whole body scintigraphy did not show further tumors (Figure 4B and C).
Figure 1.

A) Axial T2WI of the brain showing a tumor with a honeycomb appearance; B) Coronal section of the tumor (T2WI); C) Functional magnetic resonance imaging illustrating the motor area of the left hand. The tumor seems to grow in the precentral gyrus pushing fibers of the motor cortex aside; D) Fibertracking image shows the corticospinal fibers pushed anteriorly and posteriorly from the tumor; E) The white area illustrates the tumor.

Figure 2.

Macroscopical image of the resected tumor. The tumor was resected piecemeal as shown in A-C; D) Tumor growth into the calvaria. The tumor seems only to grow towards the calvaria and not to originate from it. The dura on the other side was infiltrated with tumor; E) Intraoperative image of the brain after tumor resection.

Figure 3.

Histopathological analysis reveals a monomorphous tumor of low-moderate cellularity surrounded by a fibrous pseudocapsule [A: hematoxylin and eosin (H&E); scale bar = 1000 μm]. The mononucleated cells are embedded within a chondroid matrix, without signs of atypia (B: H&E; scale bar = 50 μm). The tumor cells are strongly positive for S100 (C: scale bar = 100 μm) and negative for cytokeratine, GFAP, and EMA (not shown). Proliferative activity as determined by immunohistochemistry for Ki67 is almost absent (D: scale bar = 100 μm).

Figure 4.

A) Postsurgical computed tomography showing tumor removal; B and C) Whole body scintigram showing no further tumor dissemination.

Discussion

Chondromas are recognized as a dyschondroplasia caused by developmental errors in enchondral ossification and are slow-growing, benign tumors of cartilaginous origin.[1,3] They originate in the skull base and especially arise from the sphenopetrosal, sphenoclival or petroclival junctions. Rarely, they can be seen in the parasellar region, at the falx or arousing from the dura convexity. Multiple theories have been suggested to explain the genesis of these tumors. In their paper Colpan and colleagues listed four of them:[4] i) metaplasia of meningeal fibroblasts; ii) multipotential or perivascular mesenchymal cells in the dura mater; iii) aberrant nests of cartilage forming cells in the dura mater; iv) traumatic displacement of cartilage. They can be found as solitary lesions or as part of Ollier’s disease (multiple polysystemic enchondromatosis) or Maffuci’s syndrome[5,6] (multiple enchondromatosis associated with soft tissue angiomas). The publications regarding convexity chondromas are shown in Table 1.[2,7-28] A given predominance of the left hemisphere can be seen. The frontoparietal region is the most common localization of the tumor. The oldest patient that has been described was 55 years old, whereas most of the patients had symptoms in a young age. There was no difference among men and women. The tumor reached in most of the cases a size of 6 cm. The neurological symptoms that the patients developed depended on the localization of the tumor and were usually epileptic seizures or motor deficits. Delgado-Lopez et al. published a patient with Noonan’s syndrome and chondroma,[7] a combination which was never described before. All authors agree that operative excision of the tumor is the best treatment option. No adjuvant therapy is then needed. Since intracranial chondromas are rare tumor entities, there are no grade 1 recommendations regarding their treatment. In all patients that were surgically treated and where the tumor was completely resected, no recurrence occurred. In our patient and after macroscopically complete tumor resection we planned the next MRI scan 6 months postoperatively. The further MRI scans will then be scheduled in one, two and five years or earlier, if symptoms appear.
Table 1.

Literature review with patients with convexity chondromas.

PublicationAge/GenderLocalizationHistologic typeTumor dimensions
Berkmen and Blatt[8] (1968)33 mRight frontoparietalN/A550 g
Wu and Lapi[9] (1970)32 fLeft parietalN/A8.5×6.5×4 cm
Hardy et al.[10] (1978)22 fLeft frontoparietalN/A250 g
Matz et al.[11] (1981)20 mLeft frontoparietalI7×8 cm
Sebbag et al.[12] (1990)25 mLeft frontalN/A4×7 cm
Nakazawa et al.[13] (1993)16 fLeft parietalII5×4 cm
Salazar-Calderon Perrigo et al.[14] (1993)27 fRight frontoparietalII3×4 cm
Lacerte et al.[15] (1996)32 fRight frontalII8×6×6 cm
Khosrovi et al.[16] (2000)14 mLeft frontoparietalIIN/A
Nakayama et al.[17] (2001)47 fRight frontalIIN/A
Colpan et al.[18] (2003)40 fRight frontoparietalI5×3.5×2.5 cm
Bergmann et al.[19] (2004)30 fBifrontalN/A8×8×5 cm
Cosar et al.[20] (2005)21 fLeft frontalI2×2×2 cm
Hong et al.[21] (2005)18 mLeft frontalI3×3×4 cm
Erdogan et al.[22] (2006)14 mLeft frontalII6×7×4 cm
Delgado-Lopez et al.[7] (2007)18 mLeft frontoparietalN/AN/A
Laghmari[23] (2007)50 mFrontal parasaggitalN/AN/A
Kawabata et al.[24] (2010)48 fLeft frontalN/A1.5×1.5×6.3cm
Maheshwari et al.[25] (2011)40 mLeft frontalN/A8 cm
Uddin et al.[26] (2012)23 mLeft frontalN/A10.0×7.5×1.4cm
Yeung et al.[27] (2012)22 f pregnRight frontalN/A4.2×3.2×3.1 cm
Park et al.[28] (2013)55 fLeft frontalN/A5.9×3.5 cm
Atalay et al.[2] (2014)52 fLeft frontalN/A2×1 cm

N/A, not available.

Imaging

The diagnostic work- up includes MRI and CT sequences. In the contrast enhanced MRI images the tumor appears ringlike with intratumoral nodular enhancement and no edema.[7] In the computed tomography the tumor appears as an irregulary lobulated mass with obvious calcification. Nonetheless, a definitive diagnosis can only be made after histological examination of the tumor.

Differential diagnosis and immunhistochemistry

Intracranial chondromas present rare benign tumors of the central nervous system. The differential diagnosis primarily includes chondrosarcomas. In our case the initial diagnosis was suspicious for chondrosarcoma and therefore the histological specimen was sent to a specialized reference center. Histopathological analysis revealed a monomorphous tumor of low-moderate cellularity surrounded by a fibrous pseudocapsule. The mononucleated cells were embedded within a chondroid matrix, without signs of atypia. The tumor cells were strongly positive for S100 and negative for cytokeratine, GFAP, and EMA. Proliferative activity as determined by immunohistochemistry for Ki67 was almost absent. Therefore, the final diagnosis was chondroma. Other tumors that have to be considered in the differential diagnosis are meningiomas,[2] hemangiopericytomas, gliomas and metastases. Immunohistochemistry is an important tool in establishing the diagnosis. Since chondromas are benign tumors and grow slowly, they are only then symptomatic, when the mass effect affects vital functions of the brain. Sugiura et al. performed a molecular analysis in their case of convexity chondroma which revealed wild type IDH1/2 and expression of HMGA2.[29]

Therapy

Our patient presented with symptoms of focal mass effect and high intracranial pressure as well as seizures. As a result, we preferred a gross total resection over a possible stereotactic biopsy in order to alleviate the symptoms and to obtain a permanent histological diagnosis. Because of its huge size we also did not consider biopsy and radiosurgery as an option. Since the tumor was located in the eloquent precentral region, we preoperatively performed a digital tractography (fibertracking) and a functional MRI, which showed displacement of the fibers posteriorly and anteriorly to the tumor. Since the tumor was well defined and did not diffusely infiltrate the neighboring fibers gross total resection was feasible.

Conclusions

Supratentorial dural chondromas are rare lesions that grow slowly and cause symptoms due to local mass effect or increased intracranial pressure. If they are located in eloquent brain areas, a thorough diagnostic imaging should be performed including functional imaging and fibertracking in order to pick the best possible approach with no or minimum manipulation of the critical structures. Aim of the operation should be gross total resection. The histological diagnosis can be challenging, but once established no adjuvant therapy has to be undertaken.
  29 in total

Review 1.  Convexity dural chondroma: a case report and review of the literature.

Authors:  Efkan Colpan; Ayhan Attar; Selim Erekul; Ertekin Arasil
Journal:  J Clin Neurosci       Date:  2003-01       Impact factor: 1.961

Review 2.  [Dura mater chondroma. A case report and review of the literature].

Authors:  M Sebbag; V Schmidt; N Leboucq; J Bitoun; P Castan; P Frerebeau
Journal:  J Radiol       Date:  1990 Aug-Sep

3.  An intracranial chondroma with intratumoral hemorrhage: a case report and review of the literature.

Authors:  Jae-Hyun Park; Sin-Soo Jeun
Journal:  Brain Tumor Res Treat       Date:  2013-04-30

4.  Chondromas of the falx cerebri and dural convexity: report of two cases and review of the literature.

Authors:  Seyda Erdogan; Suzan Zorludemir; Tahsin Erman; Erol Akgul; Melek Ergin; Faruk Ildan; Huseyin Bagdatoglu
Journal:  J Neurooncol       Date:  2006-10       Impact factor: 4.130

5.  Giant chondroma arising from the dura mater of the convexity. Case report and review of the literature.

Authors:  M Nakayama; T Nagayama; H Hirano; T Oyoshi; J Kuratsu
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

6.  Intracranial falcine and convexity chondromas: two case reports.

Authors:  Murat Cosar; A Celal Iplikcioglu; Sirzat Bek; Cem A Gokduman
Journal:  Br J Neurosurg       Date:  2005-06       Impact factor: 1.596

7.  Intracranial chondroma: a rare entity.

Authors:  Veena Maheshwari; Ghazala Mehdi; Manoranjan Varshney; Anshu Jain; Sonal Vashishtha; Kavita Gaur; Vinod Kumar Srivastava
Journal:  BMJ Case Rep       Date:  2011-05-12

8.  Chondroid tumors arising from the meninges--report of 2 cases and review of the literature.

Authors:  M Bergmann; W Pinz; S Blasius; M Lentschig; H Ostertag; U Neubauer
Journal:  Clin Neuropathol       Date:  2004 Jul-Aug       Impact factor: 1.368

9.  Convexity dural chondroma: a case report with pathological and molecular analysis.

Authors:  Yoshiki Sugiura; Masaya Nagaishi; Issei Takano; Yoshihiro Tanaka; Kensuke Suzuki; Hideaki Yokoo; Akio Hyodo
Journal:  Clin Neuropathol       Date:  2015 Jan-Feb       Impact factor: 1.136

10.  Intracranial parafalcine chondroma in a pregnant patient.

Authors:  Jacky T Yeung; Terry S Krznarich; Edilberto A Moreno; Apparao Mukkamala; Aftab S Karim
Journal:  Surg Neurol Int       Date:  2012-04-25
View more
  1 in total

1.  Falcine chondroma: illustrative case.

Authors:  Melissa M J Chua; Stanley F Bazarek; David M Meredith; Liangge Hsu; Stephen C Saris
Journal:  J Neurosurg Case Lessons       Date:  2021-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.